[Bromazepam(Lexotan) and chlorprothixene(Taractan) in psychoneurotic anxiety states. A randomized, double-blind study from general practice concerning the effect, drug consumption, and risk of repeated treatment].

MLA

Fynboe, C., et al. “[Bromazepam(Lexotan) and Chlorprothixene(Taractan) in Psychoneurotic Anxiety States. A Randomized, Double-Blind Study from General Practice Concerning the Effect, Drug Consumption, and Risk of Repeated Treatment].” Ugeskrift for Laeger, vol. 143, no. 41, Oct. 1981, pp. 2641–45. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6117963&authtype=sso&custid=ns315887.

APA

Fynboe, C., Christensen, N., Halberg, T., Hansen, E. A., Holm, P., Knudsen, J. P., Lindhardt, J., Maul, B., Musaeus, C., Nielsen, M. T., & Schaumburg, E. (1981). [Bromazepam(Lexotan) and chlorprothixene(Taractan) in psychoneurotic anxiety states. A randomized, double-blind study from general practice concerning the effect, drug consumption, and risk of repeated treatment]. Ugeskrift for Laeger, 143(41), 2641–2645.

Chicago

Fynboe, C, N Christensen, T Halberg, E A Hansen, P Holm, J P Knudsen, J Lindhardt, et al. 1981. “[Bromazepam(Lexotan) and Chlorprothixene(Taractan) in Psychoneurotic Anxiety States. A Randomized, Double-Blind Study from General Practice Concerning the Effect, Drug Consumption, and Risk of Repeated Treatment].” Ugeskrift for Laeger 143 (41): 2641–45. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6117963&authtype=sso&custid=ns315887.